Protein detail
INGR1
Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119)
Entry name INGR1 | UniProt ID | EVMP score 0.50 |
Frequency 1 | Transmembrane count 1 | Protein classification CD markersDisease related genesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins |
EVMP score: annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information
Protein Names
Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119)
Protein Class
CD markersDisease related genesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins
Protein Function
- Predicted intracellular proteins
- CD markers
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Disease related genes
- FDA approved drug targets:Biotech drugs
Transmembrane
246..266; Helical
Transmembrane Count
1
Ensembl
Entrez Gene Symbol
Gene Synonym
CD119IFNGR
Gene Description
Interferon gamma receptor 1
Chromosome
6
Position
137197483-137219449
Frequency
1
EVMP Score
0.50
Fluorescence & Localization
Tissue Specificbone marrowCell SpecificBergmann gliaBlood Cell SpecificbasophilBlood Lineage Specificgranulocytes
Function & Pathway
Protein Function
- Predicted intracellular proteins
- CD markers
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Disease related genes
- FDA approved drug targets:Biotech drugs
Cellular Component
Molecular Function
Biological Process
KEGG
- hsa04060 Cytokine-cytokine receptor interaction
- KEGG:hsa04066 HIF-1 signaling pathway
- KEGG:hsa04217 Necroptosis
- KEGG:hsa04380 Osteoclast differentiation
- KEGG:hsa04630 JAK-STAT signaling pathway
- KEGG:hsa04650 Natural killer cell mediated cytotoxicity
- KEGG:hsa04658 Th1 and Th2 cell differentiation
- KEGG:hsa04659 Th17 cell differentiation
- KEGG:hsa05140 Leishmaniasis
- KEGG:hsa05142 Chagas disease
- KEGG:hsa05145 Toxoplasmosis
- KEGG:hsa05152 Tuberculosis
- KEGG:hsa05164 Influenza A
- KEGG:hsa05167 Kaposi sarcoma-associated herpesvirus infection
- KEGG:hsa05168 Herpes simplex virus 1 infection
- KEGG:hsa05200 Pathways in cancer
- KEGG:hsa05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
- KEGG:hsa05321 Inflammatory bowel disease
Reactome
- R-hsa-1280215 cytokine signaling in immune system
- R-hsa-9732724 ifng signaling activates mapks
- R-hsa-5663205 infectious disease
- R-hsa-877300 interferon gamma signaling
- R-hsa-913531 interferon signaling
- R-hsa-9679191 potential therapeutics for sars
- R-hsa-877312 regulation of ifng signaling
- R-hsa-9679506 sars cov infections
- R-hsa-9824446 viral infection pathways
Canonical Pathways
M30 Pid hdac classii pathway
Mediation Categories
Clinical-translation mediationImmune mediation
Relations & Evidence
Enzyme-Mediated Modification
2 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| IFNGR1 | JAK1 | P23458 | Y | 457 | phosphorylation | phosphoELM_MIMPPhosphoSite_MIMPMIMPHPRD_MIMPSIGNORProtMapperKEAphosphoELMLi2012SIGNOR_ProtMapper | SIGNOR:7615558KEA:8156998ProtMapper:7615558phosphoELM:8156998 |
| IFNGR1 | JAK2 | O60674 | Y | 457 | phosphorylation | KEA | KEA:8156998 |
Ligand-Receptor Signaling
59 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| cytokine_type_2 | receptor | ICELLNET | No | Yes | No | Yes | No |
| receptor | receptor | OmniPath | No | Yes | No | Yes | No |
| extracellular | extracellular | HPMR | No | No | No | Yes | No |
| extracellular | extracellular | OmniPath | No | No | No | Yes | No |
| cell_adhesion | cell_adhesion | Cellinker | Yes | Yes | No | Yes | No |
| adhesion | adhesion | OmniPath | Yes | Yes | No | Yes | No |
| cell_adhesion | cell_adhesion | OmniPath | Yes | Yes | No | Yes | No |
| transmembrane | transmembrane | UniProt_location | No | No | No | Yes | No |
| transmembrane | transmembrane | UniProt_topology | No | No | No | Yes | No |
| transmembrane | transmembrane | UniProt_keyword | No | No | No | Yes | No |
Regulatory Interaction Network
8 records.
Protein Complex Composition
4 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| IFNGR2/INFGR1 | IFNGR1IFNGR2 | P15260P38484 | 0:0 | Guide2PharmaCellChatDBSIGNORICELLNETCellinkerSPIKE | SIGNOR:SIGNOR-C142 | 15032600 |
| Type_II_IFNR | IFNGIFNGR1 | P01579P15260 | 2:3 | CellPhoneDBPDB | CellPhoneDB:Type_II_IFNRPDB:1fyhPDB:1fg9 | |
| IFNGIFNGR1IFNGR2 | P01579P15260P38484 | 2:2:2 | PDB | PDB:6e3lPDB:6e3k | ||
| IFNGR1MAD2L2SHLD2 | P15260Q86V20Q9UI95 | 0:0:0 | hu.MAP2 |
Sequence, Structure & Domains
Sequences
Length
489
Mass
54,405
Sequence
MALLFLLPLVMQGVSRAEMGTADLGPSSVPTPTNVTIESYNMNPIVYWEYQIMPQVPVFTVEVKNYGVKNSEWIDACINISHHYCNISDHVGDPSNSLWVRVKARVGQKESAYAKSEEFAVCRDGKIGPPKLDIRKEEKQIMIDIFHPSVFVNGDEQEVDYDPETTCYIRVYNVYVRMNGSEIQYKILTQKEDDCDEIQCQLAIPVSSLNSQYCVSAEGVLHVWGVTTEKSKEVCITIFNSSIKGSLWIPVVAALLLFLVLSLVFICFYIKKINPLKEKSIILPKSLISVVRSATLETKPESKYVSLITSYQPFSLEKEVVCEEPLSPATVPGMHTEDNPGKVEHTEELSSITEVVTTEENIPDVVPGSHLTPIERESSSPLSSNQSEPGSIALNSYHSRNCSESDHSRNGFDTDSSCLESHSSLSDSEFPPNNKGEIKTEGQELITVIKAPTSFGYDKPHVLVDLLVDDSGKESLIGYRPTEDSKEFS
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=P15260-1; Sequence=Displayed; Name=2; IsoId=P15260-2; Sequence=VSP_055589, VSP_055590, VSP_055591
Alternative Sequence
1..28; MALLFLLPLVMQGVSRAEMGTADLGPSS -> MLLKSPENSLLQFQFKYG (in isoform 2); 184..196; QYKILTQKEDDCD -> KRSCAFSLFSFFI (in isoform 2); 197..489; Missing (in isoform 2)
3D Structural Models
Turn
192..194; 222..224
Helix
88..90; 121..124; 149..151
Beta Strand
33..38; 40..42; 45..49; 58..65; 69..71; 74..86; 98..106; 131..136; 138..146; 168..178; 181..191; 197..205; 212..221; 234..237
3D Structure
X-ray crystallography (5)
Domain & Motif Annotations
Compositional Bias
335..348; Basic and acidic residues; 349..360; Polar residues; 379..391; Low complexity; 401..412; Basic and acidic residues; 415..429; Low complexity
Region
329..437; Disordered
Protein Families
Type II cytokine receptor family
Sequence Similarities
Belongs to the type II cytokine receptor family.
Clinical Relevance
Disease Involvement
Disease variantFDA approved drug targets
Drug Targets
FDA approved drug targets
Interaction Protein
ENSG00000111537ENSG00000140688
Interaction Count
2
Interaction Dataset
intact_biogrid_bioplexintact_biogrid